New Delhi: Remdesivir, an injectable COVID-19 drug which has been in excessive demand because the nation is hit with a second wave of novel coronavirus instances. The huge sale of the anti-COVID-19 drug in many states has led to an alleged shortage.
To help individuals get entry to the drug simply, Dr Reddy’s Laboratories’ official web site has posted particulars in regards to the availability of Remdesivir in addition to Favipiravir tablets used to deal with COVID-19 sufferers.
One solely want to go to the web site — readytofightcovid.in — which has an inventory of all of the hospitals and pharmaceutical retailers throughout completely different cities the place the 2 medication can be found. It additionally mentions cellphone numbers and addresses.
A 24/7 helpline quantity — 1800-266-708 — can be supplied for all queries associated to the COVID-19 medication. Remdesivir is getting used for the therapy of COVID-19 sufferers with extreme issues. States like Maharashtra, Gujarat and Madhya Pradesh have reported a dip in Remdesivir shares, including to the disaster.
The web site is meant to present contact particulars of the native distributors who’re engaged within the sale and distribution of the COVID-19 medicines and vaccines distributed by Dr Reddy’s Laboratories.
On Wednesday, the federal government mentioned that the manufacturing of Remdesivir might be ramped up and its costs might be decreased.
Meanwhile, with 2.34 lakh COVID-19 instances reported within the final 24 hours, India’s lively rely rose to 16.79 lakh. The nation’s complete coronavirus caseload has now soared to 1.45 crore. According to the official information, there have been 2,34,692 new COVID-19 instances, 1,23,354 recoveries and 1,341 deaths, as per the Union Health Ministry on Saturday.
